| Dr Jonathan Cates, MD | |
|
2720 Sunset Blvd, West Columbia, SC 29169-4810 | |
| (803) 936-7372 | |
| (803) 936-4102 |
| Full Name | Dr Jonathan Cates |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 9 Years |
| Location | 2720 Sunset Blvd, West Columbia, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023499381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME145361 (Florida) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 89767 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lexington Medical Center | West columbia, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lexington Health Inc | 2567872070 | 753 |
News Archive
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.
Patients who receive buprenorphine treatment for opioid addiction in an office-based setting are more likely than those receiving methadone treatment to be young men, new to drug use, and with no history of methadone treatment, Yale School of Medicine researchers report in a study published in Drug and Alcohol Dependence.
Psoriasis, a chronic skin condition that causes itchy, red, scaly patches, afflicts more than 8 million Americans and 125 million people worldwide.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
› Verified 1 days ago
| Entity Name | Lexington Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710634753 PECOS PAC ID: 2567872070 Enrollment ID: O20201208000922 |
News Archive
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.
Patients who receive buprenorphine treatment for opioid addiction in an office-based setting are more likely than those receiving methadone treatment to be young men, new to drug use, and with no history of methadone treatment, Yale School of Medicine researchers report in a study published in Drug and Alcohol Dependence.
Psoriasis, a chronic skin condition that causes itchy, red, scaly patches, afflicts more than 8 million Americans and 125 million people worldwide.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Cates, MD Po Box 6069, West Columbia, SC 29171-6069 Ph: (803) 936-7372 | Dr Jonathan Cates, MD 2720 Sunset Blvd, West Columbia, SC 29169-4810 Ph: (803) 936-7372 |
News Archive
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.
Patients who receive buprenorphine treatment for opioid addiction in an office-based setting are more likely than those receiving methadone treatment to be young men, new to drug use, and with no history of methadone treatment, Yale School of Medicine researchers report in a study published in Drug and Alcohol Dependence.
Psoriasis, a chronic skin condition that causes itchy, red, scaly patches, afflicts more than 8 million Americans and 125 million people worldwide.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
› Verified 1 days ago
Dr. Robert Anthony Leonardi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2728 Sunset Blvd Ste 300, West Columbia, SC 29169 Phone: 803-744-4940 Fax: 803-744-4938 | |
Dr. Vijaya Korrapati, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 E Medical Ln Ste 400, West Columbia, SC 29169 Phone: 803-794-7511 Fax: 803-794-7751 | |
Parthivkumar N Kundaria, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2720 Sunset Blvd, West Columbia, SC 29169 Phone: 803-791-2480 Fax: 803-936-4102 | |
Jonathan Kyle Hewett, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2728 Sunset Blvd Ste 300, West Columbia, SC 29169 Phone: 803-744-4940 Fax: 803-744-4938 | |
Dr. Carl A White, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 146 N Hospital Drive, Suite 530, West Columbia, SC 29169 Phone: 803-796-7270 Fax: 803-796-0106 | |
Perrie L Ryan, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 E Medical Ln Ste 400, West Columbia, SC 29169 Phone: 803-794-7511 Fax: 803-794-7751 | |
Dr. Christopher Patrick Rowley, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2728 Sunset Blvd Ste 300, West Columbia, SC 29169 Phone: 803-744-4940 Fax: 803-744-4938 |